A significant advance in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant suppressor protein is frequently disabled in many forms of cancer, leading https://social4geek.com/story7665854/nanobodies-restore-p53-new-promising-pathway-for-malignant-therapy